Skip to main content

Table 3 Demographics and clinical characteristics of reproductive-aged female patients meeting inclusion criteria

From: Contraceptive use in women with inherited metabolic disorders: a retrospective study and literature review

 

Total

Adolescents (12–21)

Adults (> 22)

Number

221

111

110

Age (mean ± SD)

25.2 ± 11.3

16.2 ± 2.6

25.2 ± 9.3

Insurance (n, %)

   

 Private only

117 (52.9)

59 (53.2)

58 (52.7)

 Medicare only

5 (2.3)

1 (0.9)

4 (3.6)

 Medicaid only

39 (17.6)

22 (19.8)

17 (15.5)

 Self pay only

1 (0.5)

0 (0)

1 (0.9)

 Private + Medicare

4 (1.8)

1 (0.9)

3 (2.7)

 Private + Medicaid

42 (19)

26 (23.4)

16 (14.5)

 Medicaid + Medicare

12 (5.4)

2 (1.8)

10 (9)

 Private + Medicaid + Medicare

1 (0.5)

0 (0)

1 (0.9)

Race (n, %)

   

 African American

25 (11.3)

12 (10.8)

13 (11.8)

 Asian

5 (2.3)

3 (2.7)

2 (1.8)

 Hispanic

14 (6.3)

9 (8.1)

5 (4.5)

 White

155 (70.1)

69 (62.2)

86 (78.2)

 Other

22 (10)

18 (16.2)

4 (3.6)

Residence (n, %)

   

 Lives with parents/caregiver

154 (69.7)

103 (92.8)

51 (46.3)

 Lives independently

64 (29)

8 (7.2)

56 (50.9)

 Lives in group home

3 (1.4)

0 (0)

3 (2.7)

Intellectual disability (n, %)

82 (37.1)

46 (41.4)

36 (32.7)

Diagnosis (n, %)

   

 Aminoacidopathy

41 (18.6)

19 (17.1)

22 (20)

 Disorder of carbohydrate metabolism

15 (6.8)

11 (9.9)

4 (3.6)

 Fatty acid oxidation disorder

21 (9.5)

15 (13.5)

6 (5.5)

 Lysosomal storage disorder

31 (14)

9 (8.1)

22 (20)

 Mitochondrial disorder

59 (26.7)

28 (25.2)

31 (28.2)

 Organic acidemia

22 (10)

14 (12.6)

8 (7.2)

 Urea cycle disorder

22 (10)

7 (6.3)

15 (13.6)

 Other

10 (4.5)

8 (7.2)

2 (1.8)